IQVIA announced its development of a Software as a Service (SaaS) safety platform that scales to address the drug safety and surveillance challenges of life sciences organizations, ranging from emerging biopharma to large pharmaceutical companies. This SaaS solution is built to allow access from multiple users, across multiple locations and will run on the Salesforce architecture, the global leader in CRM and provider of SaaS solutions. IQVIA’s multi-tenant safety platform will combine IQVIA’s deep domain expertise, three thousand plus drug safety professionals, and innovative process automation, machine learning and artificial intelligence technologies, with IQVIA’s real world and regulatory data to deliver actionable insights and streamline pharmacovigilance operations. A fundamental addition for IQVIA Technologies, the SaaS platform will eliminate the need for costly upgrade projects and long validation cycles. By leveraging automation to eliminate the costly and repetitive manual processes associated with pharmacovigilance, organizations will be able to evolve to zero-touch processing.